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Multiple factors affect the thrombin-catalyzed conversion of fibrinogen to fibrin, including: fibrinopeptide (FP A and FPB) release leading to exposure of two
types of polymerization domains ("A" and "B," respectively) in the central portion of the molecule, and exposure of a noncatalytic "secondary" thrombin-binding
site in fibrin. Fibrinogen containing the FP A sequence
but lacking the BtH-42 sequence ("des-(BtH-42)-fibrinogen"), was compared to native fibrinogen (containing l:oth FPA and FPB) to investigate the role
played by B,81-42 in the polymerization of a-fibrin
(i.e. fibrin lacking FPA), to compare reptilase and
thrombin cleavage of FPA from fibrinogen, and to
explore the location and function of the secondary
thrombin-binding site. Electron microscopy of evolving polymer structures(µ., 0.14; pH 7.4) plus turbidity
measurements, showed that early thin fibril formation
as well as subsequent lateral fibril associations were
impaired in des-(B,81-42)-a-fibrin, thus indicating
that the B,81-42 sequence contributes to the A polymerization site. Reptilase-activated des-(B,81-42)-a-fibrin polymerized even more slowly than thrombinactivated des-(B,81-42)-a-fibrin, differences that disappeared when repolymerization of preformed fibrin
monomers was carried out. Since existing data indicate
that thrombin releases FP A in a concerted manner,
resulting in relatively rapid evolution of fully functional divalent a-fibrin monomers, it can be inferred
that delayed fibrin assembly of reptilase fibrin is due
to slower formation of divalent a-fibrin monomers.
Thrombin-activated des-(B/H-42)-a-fibrin polymerized more rapidly at low ionic strength (µ., 0.04) than
did native a,,8-fibrin, a reversal of their behavior at
physiological ionic strength (µ., 0.14), Concomitant
measurement of FP A release revealed modest slowing
of release at low ionic strength from des-(B,81-42)fibrinogen (t,,.,, 36.5 versus 21.5 min) and marked slowing from native fibrinogen (t,,.,, 138 versus 22.2 min).
This behavior correlated with increased thrombin
binding to native a,,8-fibrin at low ionic strength, coupled with weak thrombin binding to des-(B,81-42)-afibrin, and indicates that secondary thrombin binding
plays an important role in regulating thrombin diffu* This investigation was supported by National Heart, Lung, and
Blood Institute Grants HL-28444 and HL-36221. An abstract of this
work was presented at the XII Congress of the International Society
on Thrombosis and Haemostasis (1), August, 1989 and at the Ninth
International Workshop on Fibrinogen, Kyoto, Japan, August, 1989.
The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby
marked "advertisement" in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
§ To whom reprint requests should be addressed: Sinai Samaritan
Medical Center, 836 North 12th St., Milwaukee, WI 53233.

sion and catalytic activity. Des-(B,81-42)-fibrinogen
lacks or has a markedly defective secondary thrombinbinding site, from which we conclude that the B,81542 sequence in fibrin plays a major role in forming or
providing this site.

Under physiological conditions, a,{j-fibrin assembly commences with thrombin-catalyzed release of FPA 1 from the
amino termini of fibrinogen Aa chains accompanied by slower
release of FPB from B/3 chains (2, 3). Selective release of FPA
by reptilase, which is capable of releasing only this fibrinopeptide (4), or release of FPB by copperhead venom procoagulant enzyme (5), is sufficient to initiate fibrin polymerization, forming Cl'.· or /3-fibrin, respectively. Mature a- and
a,/3-fibrin clots evidently assemble from a network of thin
fibrils which undergo lateral aggregation resulting in increased fiber thickness and branching (6-11). The /3-fibrin
clot matrix shares many structural features with a· and a,/3fibrin, including formation of twisting fibrils, trimolecular
branch points (11), and ultimately, thick striated fibers (10).
However, the {1-fibrin matrix structure is weaker than a- or
a,(1-fibrin and is readily dissociable at 37 °C (5).
Release of FPA and FPB exposes two types of polymerization sites in the amino-terminal regions of fibrinogen molecules (12) which appear to function cooperatively in fibrin
self-assembly (5). FPA release exposes an "A" polymerization
site in its central region (E domain) which subsequently aligns
with a complementary "a" site in the outer region (D domain)
of another molecule (3, 13) to form staggered overlapping twostranded fibrils. FPB release uncovers an independent "B"
polymerization site (5). The complementary "b" site is apparently formed through cooperative interactions resulting from
participation and/or proper alignment of two D domains in
the a,,8-fibrin polymer (5, 13).
Existing evidence suggests that the A polymerization site
is comprised of more than a single peptide sequence, one
portion of which is located at the amino-terminal region of
the fibrin a-chain, beginning at Aa 17, the site of thrombin
cleavage. Peptide sequences that are homologous with Aa-1720 (e.g. Gly-Pro-Arg-Val) inhibit fibrin polymerization (14,
15). Another portion of the A site is probably in the aminoterminal region of the fibrinogen B/3 chain. Photo-oxidation
of B,8-His-16 impaired binding of the E domain of fibrin to
fibrinogen (A to a polymerization) but did not impair its
1
The abbreviations used are: FPA, fibrinopeptide A; FPB, fibrinopeptide B; a-fibrin, fibrinogen lacking FPA; tl·fibrin, fibrinogen
lacking FPB; a,tl-fibrin, fibrinogen lacking FPA and FPB; Aa, B/3,
fibrinogen chains containing FPA and FPB, respectively; des-(B/:1142)-fibrinogen, fibrinogen lacking B(H-42; des-AB-NDSK, aminoterminal disulfide knot fragment lacking FP A and FPB.
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binding to D dimer-Sepharose, which presumably contains
the b site (16). Deletion of B,8-9-72, as occurs in Fibrinogen
New York I, results in impaired fibrin polymerization (17,
18). Furthermore, selective removal of B/31-42 by protease III
from Crotalu.~ atrox venom, resulted in a molecule (des-(B.8142)-fibrinogen) lacking a cleavable B peptide whose rate of
polymerization as a-fibrin, as assessed by clot turbidity, was
180-fold slower than that of native a,,S-fibrin (19). Since
development of clot turbidity is an exponential function of
fiber width (20), these results suggest that thick fiber formation (i.e. lateral fibril association) is markedly impaired.
Fibrinogen contains two types of sites having demonstrable
thrombin affinity. The first type, termed the "substrate site,"
involves regions concerned with thromhin-mediated release
ofFPA and FPB (21-23). Following fibrinopeptide release, a
"secondary" anionic binding site on fibrin becomes measurable (24-27). There is less than one (0.4 mol/mol) high affinity
site (K., 5 to 6 x 105 M- 1) per fibrin molecule (25, 28). It can
be increased at low ionic strength, abolished at high ionic
strength, and is located in the fibrin E domain (27, 29, 30).
Studies by Liu et al. (17, 18) with fibrinogen New York I have
suggested that at least a part of this site is located in the
amino-termimal region of the fibrin JS-chain, since this abnormal molecule lacks the Bf,9-72 sequence, and after conversion to fibrin, does not bind thrombin.
The present studies were initiated to assess the function of
the B/31-42 segment of the molecule in fibrin polymerization.
In order to do this, we compared the polymerization of nativeand des-(/31-42)-fibrin formed from thrombin- or reptilasetreated fibrinogen, evaluated the ultrastructure of evolving
fibrin matrices, and measured binding of thrombin to native
and des-(B/31-42)-fibrin. Our findings offer new insights into
the role played by this region of the molecule in the fibrinogen
to fibrin conversion, both with respect to its thrombin-binding
properties and its role in the fibrin polymerization process.
MATERIALS AND METHODS

Tris was obtained from Aldrich. Reptilase (Atroxin), phenylmethylsulfonyl fluoride, and Coomassie Brilliant Blue R-250 were purchased from Sigma. Trasylol (aprotinin) was obtained from Mobay
Chemical Corp. Human thrombin (7100 units/ml, 2334 units/mg)
was generously supplied by Dr. John W. Fenton II, New York Department of Health, Albany, NY. Common chemicals were reagentgrade or better.
Native human fibrinogen and des-(B(:H-42)-fibrinogen were prepared as described (31) and stored freeze-dried at -20 °C. The lyophylized fibrinogens were redissolved with gentle stirring in 150 mM
Tris-HCI buffer, pH 7.5-8.0, containing 0.1 mM phenylmethylsulfonyl
fluoride and Trasylol, 10 kallikrein-inactivating unit/ml, and dialyzed
against 50 mM Tris-HCI, 100 mM NaCl, pH 7.4, buffer, containing
Trasylol, 5 kallikrein-inactivating unit/ml. The subunit structure of
these materials was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (32) on 1.5-mm polyacrylamide slab gels
(5% gels, nonreduced samples; 9% gels, reduced samples).
To express enzyme activity in standard units, thrombin or reptilase
clotting activity was calibrated in a Fibrometer Precision Coagulation
Timer (BBL) at room temperature by adding 100 µl of enzyme diluted
in 50 mM Tris, 100 mM NaCl, pH 7.4, buffer to 300 µl of citrated
plasma. One unit of activity was defined as the amount of enzyme
that clotted pooled citrated human plasma within 15 ± 0.5 s.
The rate of fibrinopeptide release from fibrinogen was determined
by incubating fibrinogen (3-5 mg/ml) in 0.15 M ammonium acetate
buffer, pH 7.5, or in 0.05 M ammonium acetate buffer, pH 7.5, with
thrombin (0.05 to 0.2 unit/ml) or reptilase (0.075-0.2 unit/ml) at
room temperature for periods of up to 360 min. The reaction was
terminated by heating the mixture in a boiling water bath for 3 min,
the supernatant solution clarified by filtration, and FPA quantified
by high performance liquid chromatography (33). Over the range of
enzyme studied, the rate of FP A release (t,,., min) was proportional
to the amount of enzyme added to the reaction mixture. Under
physiological buffer conditions (pH 7.4; µ. = 0.14), thrombin that had

1.6

A.

1.2
NI+ Ci¥.•

E
C

0

It)

0.8

M
<(
dos BP 1-<1~

0.4
des

t

+ Ca''

Bµ 1-42 t
I

0

20

40

60

Time (min)

1.6

B.
des

aµ 1-•2 •+ca•·

1.2

E
C

~ o.a

M

<
0.4

0

20

40

60

Time (min)

FIG. 1. Thrombin-catalyzed polymerization of native and
des-(B/31-42)-fibrinogen. The reaction was carried out at room
temperature in 50 mM Tris, 100 mM NaCl, pH 7.4 (µ, 0.14; panel A),
or in 60 mM Tris, pH 7.4, buffer (µ, 0.04; panel B). Polymerization
was initiated by adding thrombin (0.1 unit/ml, final concentration)
to the fihrinogen solutions (500 µg/ml) and was monitored at 350 nm
as a function of time.
been calibrated against a plasma standard released FPA 30-38%
(mean, 34%, n = 4) faster from purified native fibrinogen than did
an equivalent number of units of reptilase. 2 Thus, in experiments
comparing thrombin directly with reptilase, enzyme activity was
adjusted to yield identical FPA release rates (e.g. l.3 units of reptilase /
unit of thrombin).
Fibrin polymerization was monitored at 350 nm at room temperature in a Gilford Response recording spectrophotometer. Reaction
mixtures contained fibrinogen (native or des-(B,81-42)-fibrinogen) at
0.5, 0.1, or 0.05 mg/ml in 50 mM Tris-HCI, 100 mM NaCl, pH 7.4,
buffer (µ, 0.14) or in 50 mM Tris, pH 7.4, buffer (µ., 0.04). When
included, CaC12 was present at a final concentration of 10 mM.
Polymerization was initiated by the addition ofthrombin or reptilase.
Thrombin binding by native and des-(BPl-42)-fihrin was measured
in the 50 mM Tris buffer system (µ, 0.04 or 0.14) by incubating
fi.brinogen (0.50 or 1.85 mg/ml) with thrombin (1-25 units/ml, final
concentration) at room temperature for 2 h. The resulting clots were
synerized and thrombin activity remaining in the clot liquor and in
the clot itself was assayed at room temperature in 50 mM Tris, 100
mM NaCl, pH 8.3, buffer using S-2238 (Kabi) as substrate (0.1 mM,
final concentration). Control samples contained thrombin alone incubated under identical conditions.
Fibrin monomer repolymerization studies were performed as described by Gralnick et al. (34). Reaggregation of fibrin monomer from
acetic acid solutions was initiated by diluting an aliquot of the fibrin
solution into at least a 10-fold excess of 50 mM Tris-HCl, 100 mM
NaCl, pH 7.4, buffer (final fibrin concentration, 0.5 mg/ml).
Samples of native fibrin or des-(B/31-42)-fibrin for negative stain2 The reason for the difference in the functional activities of
thrombin and reptilase may be due to a relatively greater propensity
of plasma to inhibit thrombin compared to reptilase.
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ing electron microscopy were formed at room temperature (µ, 0.14)
as 50-µl drops (0.1 mg/ml fibrinogen) in a Petri dish, incubated for
0-20 min with thrombin or reptilase (0.1 unit/ml, final), picked up
on glow discharged carbon/formvar-coated grids, and then negatively
contrasted with 2% (w/v) uranyl acetate. For processing by the critical
point drying technique, the clots were formed overnight and critical
point-dried as previously described (10).
Electron microscopy was performed in a Philips Model 400 transmission electron microscope at 80 or 120 kV. Fibrin fiber diameters
were measured from 8 :X 10 enlargements of micrographs. All fibers
within randomly selected areas of each photograph were measured
and averaged.
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RESULTS AND DISCUSSION

#-

Thrombin-catalyzed Polymerization of Native and Des(B/jJ-42)-/ibrin-Des-(B,61-42)-fibrinogen (0.5 mg/ml) at
physiological pH and ionic strength {µ, 0.14) polymerized at
a much reduced rate when compared to native fibrinogen
(M~~,o/min, des-(B/jl-42)-fibrin, 0.01/min; native fibrin,
0.28/min) (Fig. lA), even though the rate of FPA release did
not differ significantly (t.,,, des-(B,81- 42)-fibrinogen, 20.2 min;
native fibrinogen, 21.4 min at 0.2 unit/ml, thrombin). Addition of calcium to these mixtures resulted in a small increase
in the polymerization rate of native fibrin and a more marked
increase in that of des-(B/jl-42)-fibrin (1.3- versus 6-fold). In
each case, the lag period before the onset of turbidity was
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FIG. 3. FPA release from native (panel A) and des-(B.Bl42)-fibrinogen (panel B) at physiological ionic strength (µ,
0.14; closed symbols) and at low ionic strength {µ, 0.04; open
symbols). Native and des-(B81-42)-fibrinogen (3 mg/ml)
were incubated with thrombin (0.2 unit/ml}, and the FPA
content determined at various time intervals.
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FIG. 4. Thrombin binding to native and des-(B81-42)-fibrin. Fibrin clots were formed in 50 mM Tris, 100 mM NaCl, pH 7.4,
buffer (µ, 0.14; panel A), or in 50 mM Tris, pH 7.4, buffer (µ, 0.04;
panel B), with various levels of thrombin (1-25 units/ml, final} and
incubated at room temperature for 2 h. The clots were removed and
the clot liquor assayed for residual thrombin activity: •, • , native
fibrin, 0.50 mg/ml; D., A, native fibrin, 1.85 mg/ml; O, • • des-(B8142)-fibrin, 0.50 mg/ml; 0, e, des-(B{tl-42)-fibrin, 1.85 mg/ml. Assay
of clot-bound thrombin yielded similar curves to those shown for the
clot liquor. The recovery of bound and supernatant thrombin activity
ranged from 82 to 94% of the amount added.

FIG. 2. Electron micrographs of negatively stained native
(panels A and C) and des-(B.Bl-42) (panels Band D) polymerizing fibrin. Fibrinogen (0.1 mg/ml) was incubated at room temperature with thrombin or reptilase for up to 20 min. Panels A and
B, 50 mM Tris, 100 mM NaCl, pH 7.4, buffer plus thrombin at 3 min;
panels C and D, 50 mM Tris, 100 mM NaCl, pH 7.4, buffer plus
reptilase at 2 min; the grid surface in panel D is covered with
unpolymerized fibrin(ogen) molecules (arrows). (Bar in panel A represents 200 nm in panels A and B and 100 nm in panels C and D.)
TABLE

l

Thickness of mature native and des-(B{jl-42)-fibrin fibers

Mean fiber width (nm) ± S.D. (range, nm).
Native fibrinogen

Thrombin
Thrombin + Ca2+
Reptilase
Reptilase + Ca2+

88 ± 48 (22- 288)
116 ± 71 (25-357)
77 ± 54 {14-220)
88 ± 52 (22-220)

Des-(Bi,1-42) •fibrinogen

61 ±
63 ±
101 ±
129 ±

39 (11- 211)

30 (7-192)
61 {36-266)
79 (26-317)

longer for des-(B,Bl-42)-fibrinogen than it was for native
fibrinogen.
Compared with physiological conditions, at low ionic
strength (µ, 0.04) there was a 2-fold decrease in the polymerization rate of native fibrin, whereas the polymerization rate
of des-(B,81-42)-fibrinogen was increased 18-fold and was
even more rapid than that of native fibrin (Fig. lB). Addition
of calcium resulted in augmented polymerization rates for
both fibrins, but the polymerization rate of des- (B/jl- 42)fibrin remained greater than that of its normal counterpart.
The ultimate turbidity developed by des-(B/31-42)-fibrin in
the absence or presence of calcium was lower than that for
native fibrin under the same conditions. Similar polymerization behavior was observed at lower protein concentrations
(0.1, 0.05 mg/ml; results not shown).
The prolonged lag period, slow polymerization rate, and
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Fm. 5. Reptilase-induced polymerization of native and des(B/31-42)-fibrinogen. The reaction was carried out at room temperature in 50 mM Tris, 100 mM NaCl, pH 7.4, buffer. Reptilase (0.13
unit/ml, final concentration) was added to fibrinogen solutions (500
µg/ml) to initiate the reaction and polymerization was monitored at
350 nm as a function of time.
TABLE II

Lag time, polymerization rate, and turbidity developed during
repolymerization of native and des-(B/31-42)-fibrin morwmer
Fibrin monomer preparation

Des-(B/31-42)
Des-(B/31-42)
Des-(B/31-42)
Des-(B/11-42)
Native (Ila)
Native (R)

(Ila)
(R)

(Ila) + Ca 2+
(R) + Ca2•

Native (Ila) + Ca2+
Native (R) + Ca2+

Lag time"

min
2.6
2.3
0.1
0
2.1
3.8
0
0

Maximum
rate

A 3"" at
120 min

LlA:iso/min

O.Dl7
0.014
0.236
0.254
0.354
0.192
0.709
0.624

0.262
0.251
0.448
0.471
1.066
0.759
0.641
0.725

" The lag time was measured from the time of fibrin monomer
dilution to the onset of turbidity.

decreased final turbidity of des-(B,Bl-42)-fibrin could result
from delayed fibril formation, retarded lateral association of
fibrils into thicker cables, or both. To explore these possibilities, evolving fibrin clots were examined by electron microscopy to assess the rate of fibril and thick fiber formation (Fig.
2). In native fibrin (µ, 0.14), thin fibrils were plentiful after
2-min incubation with thrombin, either in the absence or
presence of calcium ions. At 3 min the sample contained thick
fibers as well as fibrils (Fig. 2, panel A). In contrast, the des(B/11-42)-fibrin sample (panel B) contained only a few thin
fibrils. Thus, the slow polymerization rate of des-(B,81-42)fibrin is attributable to delayed formation of primary fibrillar
structures, which may in turn contribute to delayed lateral
fibril association.
Ultrastructural examination of critical point-dried mature
native a,{:l-fibrin formed atµ 0.14, pH 7.4, in the presence or
absence of calcium, yielded a typical clot matrix composed
predominantly of thick branching striated fibers (Table I).
The matrix formed from mature thrombin-treated des-(B/:1142)-fibrin displayed a similar structure, although under either
condition the mean fiber width was less than that of the
native fibrin fibers and the augmenting effect of calcium ions
on fiber thickness was minimal. These foregoing results,
demonstrating that thin fibril as well as thick fiber formation
is impaired in the des-(B/31-42)-fibrin assembly process, indicate that the B/:11-42 segment contributes significantly to
the A polymerization domain in the native molecule.
Thrombin Binding to Des-(B/31-42)-fibrin-Previous stud-
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ies with native fibrinogen showed that the accelerating effect
of low ionic strength on polymerization is evidently offset by
a decreased rate of FPA cleavage due to increased binding of
thrombin to the secondary site on fibrin (35-37). In contrast
to the slowed polymerization of native fibrin at low ionic
strength (Fig. lB), we observed an acceleratory effect of low
ionic strength on des-(B,Bl-42)-fibrin polymerization. To investigate the possibility that this effect was attributable to
decreased thrombin binding by des-(B,81-42)-fibrin, relative
to that of native fibrin, we measured both the rate of thrombin-mediated FPA release as well as the binding of thrombin
to these fibrin molecules. At physiological ionic strength,
thrombin (0.2 unit/ml) released FPA from native fibrinogen
with at,;, of 22.2 min and from des-(B/H-42)-fibrinogen with
at½ of 21.5 min (Fig. 3). At ionic strengthµ 0.04, there was
more than a 6-fold decrease in the FP A release rate from
native fibrinogen (t,/2, 138 min), but only a modest decrease in
the release rate from des-(B/H-42)-fibrinogen (t½, 36.5 min).
Under physiological buffer conditions, native fibrin (0.50
mg/ml) bound 20-60% of the added thrombin (Fig. 4),
whereas at a higher fibrin concentration (1.85 mg/ml), 5075% of the added thrombin was bound. At low ionic strength,
70-90% of the added thrombin bound to native fibrin. In
contrast, thrombin binding to des-(B/H-42)-fibrin was undetectable under physiological buffer conditions at any fibrin
concentration, and was very low (2-20%) at low ionic
strength.
These findings suggest an explanation for the more rapid
polymerization of des-(B,81-42)-fibrin at low ionic strength
compared with native a,P-fibrin. Since secondary thrombin
binding is only minimally expressed in des-(B,81-42)-fibrin,
the acceleratory effect of low ionic strength,per se, on polymerization is augmented by an FPA cleavage rate that is only
slightly less than that observed at physiological ionic strength.
The addition of calcium, which further reduces the extent of
secondary thrombin binding to fibrin (25, 29), enhances polymerization by increasing the thrombin effectively available
for fibrinopeptide cleavage as well as by augmenting lateral
fiber association (38, 39). Furthermore, the existence of a
deficient A polymerization site and the possible absence or
modification of the B polymerization site in des-(Bp'l-42)·
fibrinogen, probably account for the finding that thrombinactivated des-(B/H-42)-fibrin forms thinner fibers than the
corresponding native fibrin despite a greatly reduced polymerization rate, which by itself would favor thick fiber formation.
These observations on thrombin binding to des-(B/'11-42)fibrin clearly indicate that the B,8-15-42 sequence in fibrin
plays a major role in forming or providing at least a portion
of the high affinity secondary thrombin-binding site, and are
supported by the finding that Fibrinogen New York I, which
lacks B,89-72 (18), fails to bind thrombin (17). Our conclusion
as to the location of the secondary thrombin-binding site does
not agree with that of Vali and Scheraga (30), who positioned
this site within Aal 7-51. Their conclusion was based on the
finding that this sequence was common to all fragments or
peptides derived from fibrinogen that bound to active siteinhibited thrombin (i.e. des-AB-NDSK, fibrin, or fibrinogen
fragment E, and S-sulfonated Ao:17-78). This interpretation
is open to question, since as summarized below, it appears
that these fragments may each have bound to thrombin at a
site in their structure that did not involve the native Aal 751 sequence. First, their S-sulfonated Aal 7-78 peptide contained four negative charges inserted on cysteine residues at
positions 28, 36, 45, and 49 (40) that are not present in the
native Aa sequence. Furthermore, it has been shown that the
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Aal7-27 sequence preceding the Aa chain disulfide bridges
does not bind to thrombin (27). Therefore, it seems likely
that sulfonation of cysteine residues in Aal 7-78, rather than
any intrinsic quality of this region of the native Aa chain,
provided the type of anionic environment required for thrombin binding. Second, it seems highly improbable that the Aa
chain sequence of the plasmic fibrinogen E fragment began,
as they asserted, at Aa 17 (i.e. lacking FPA and consequently
the intact Aa chain thrombin substrate-binding site) because
plasmin does not cleave at this position (40-42). Therefore,
at least some E fragments contained an intact amino-terminal
Aa sequence (i.e. a primary substrate-binding site) to which
thrombin could bind. On the other hand, des-AB-NDSK and
fibrin fragment E each lack a substrate-binding site for thrombin, but both contain the B,615-42 sequence, which we believe
contributes to or constitutes the secondary thrombin-binding
site in fibrin.
Kaczmarek and McDonagh (43) studied binding of thrombin to fibrinogen fragments D and E, or to the S-carboxymethyl derivatives of the fibrinogen Aa, B{:l, and 'Y chains.
They concluded that the secondary thrombin-binding site(s)
was situated on all three peptide components of the E fragment (a20-78, /154-120, -yl-53). Their differing conclusion
seems attributable mainly to the fact that under their conditions of complexation and dissociation, they were not measuring a high affinity secondary binding site since the interactions they identified were abolished under physiological
buffer conditions in the absence of glutaraldehyde fixation.
At most, it appears they were assessing a "low" affinity
thrombin binding activity (28).
The exact nature of the nonsubstrate thrombin-binding site
is not well understood. It may be available in the fibrinogen
molecule itself, or more likely, is expressed only after fibrinogen has been converted to fibrin. Data on the association
constants for the substrate-binding sites and the secondary
noncatalytic thrombin-binding site (25, 28, 44-46) indicate
that these values are similar, a finding that would be consistent with the secondary site remaining cryptic until fibrinopeptide release had occurred. Our findings indicating that
B{:115-42 is a constituent of the secondary site, would place
this site near to or superimposed upon the B{:l chain catalytic
cleavage site. In this situation, thrombin would remain bound
in the B{:115-42 region after it had cleaved FPB. Additional
studies will be required to resolve this interesting question.
Comparison of Reptilase- and Thrombin-catalyzed Fibrin
Polymerization-To distinguish the contribution of the B,Bl42 sequence to the A polymerization site in native fibrin from
its contribution to the B site, turbidity measurements were
made using reptilase for clot initiation, since only FPA and
therefore only the A site is exposed in fibrinogen by reaction
with reptilase (4). Under physiological buffer conditions in
the presence of reptilase, des-(B/H-42)-fibrinogen displayed
a longer lag period (11.7 versus 5.1 min) and a 28-fold slower
polymerization rate than did native fibrinogen (Fig. 5). As
was observed with thrombin, the addition of calcium shortened the lag period in both cases, and increased the polymerization rate of native and des-(B,Bl-42)-a-fibrin 2- and 9fold, respectively. These observed differences between native
and des-(B{:ll-42)-a-fibrin were not due to a variable enzymatic effect since FP A was released by reptilase from both
(0.2 unit/ml) at nearly the same rate (t,,.,, native fibrinogen,
26.1 min; des-(Bi'H-42)-fibrinogen, 24.7 min).
As assessed by electron microscopy, native fibrinogen
treated with reptilase formed fibrils within 60 s; at 2 min,
coalescence into thick fibers was evident (Fig. 2, panel C).
Under the same conditions, there were virtually no identifia-

ble thin fibrils in the des-(B.Bl-42)-fibrin specimen (panel D);
fibrils and thick fibers did not appear in this specimen until
20 min had elapsed (not shown).
When critical point-dried specimens of mature a-fibrin
clots were examined, the matrix formed from the native
molecule was similar to that of native a,,B-fibrin (Table I).
The addition of calcium ions to the reaction mixture resulted
in somewhat thicker fibers. Reptilase-treated des-(BtH-42)a- fibrin fibers were somewhat thicker than fibers obtained
from thrombin-treated des-(B/31-42)-a-fibrin, an expected result, since fiber width in a mature clot is known to be inversely
related to the rate of fibrin generation (8, 47, 48).
Under conditions normalized with respect to FPA release,
both native and des-(B{:ll-42)-fibrinogen polymerized more
slowly in the presence of reptilase than they did when they
were activated with thrombin (c/. Figs. IA and 5). This finding
is especially remarkable for des-(B{:ll-42)-fibrinogen which
yields identical molecules of a-fibrin with either enzyme.
In order to further explore the observed differences between
thrombin- and reptilase-catalyzed polymerization of fibrinogen, the repolymerization of fibrin monomer that had been
prepared from native or des-(B/31-42)-fibrinogen by treatment with either reptilase or thrombin was studied (Table II).
Native a,/3-fibrin monomer, no doubt due to the presence of
an active B as well as an A polymerization site, repolymerized
more rapidly than did the native reptilase a-fibrin preparation. However, when reptilase or thrombin des-(B.Bl-42)-afibrin monomer was repolymerized, there were no differences
in polymerization under either buffer condition, indicating
that observed differences between thrombin- and reptilasecatalyzed conversion of fibrinogen to fibrin are attributable
to events occurring during FPA release.
Ferry and co-workers (49-51) calculated that thrombin
catalyzes the release of the second FPA from a fibrinogen
molecule 16 times faster than the first FPA, thus inferring
that thrombin acts in a positively cooperative manner on
fibrinogen, favoring production of divalent a-fibrin molecules.
This idea is supported by the work of Wilf and Minton (52),
who showed by size exclusion chromatography that fibrin/
fibrinogen oligomers present early in the clotting reaction
were predominantly trimers consisting of one divalent a.fibrin molecule in complex with two molecules of fibrinogen.
Given the above evidence for concerted thrombin action on
fibrinogen, our findings suggest that since the rate of FP A
release is the same for both enzymes, delayed assembly of
reptilase fibrin is related to slower evolution of fully functional
divalent a-fibrin molecules, perhaps due to more random FPA
release by reptilase.
In summary, these investigations have led to two conclusions regarding the function of the fibrinogen B{:ll-42 sequence. 1) The B/31-42 sequence contributes to formation of
the A polymerization site that is exposed when FPA is released
from the fibrinogen molecule. 2) The B,815-42 sequence plays
a major role in forming or providing the secondary thrombinbinding site on the fibrin molecule.
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